TA Associates has agreed to acquire a 60% stake in India-based OmniActive Health Technologies for USD150m, facilitating an exit for Everstone Capital and several HNIs. Everstone held a 35% stake in the company. Read more… Read More
Investcorp has acquired a majority stake in Singapore-based instant cereal and beverage company Viz Branz from the company’s CEO, Mr. Ben Chng. Read more… Read More
CDC Group and Development Partners International have partnered to form Zanzibar Pharma, a pharmaceuticals platform through which they have agreed to acquire Celon Laboratories, an India-based drugmaker backed by Sequoia Capital, for USD75m. Read more… Read More
GIC led a USD200m Series D2 for China-based edtech Aixuexi Education Group, bringing the total capital raised by the company through its Series D to over USD300m. Warburg Pincus and Tencent contributed to the Series D in 2019. Read more… Read More
IDG Capital led a USD80m Series B for China-based biotech firm PTM Biolabs, with participation from Fortune Capital, Highlight Capital, and SDIC Venture Capital. Read more… Read More
Ascent Capital has reached a USD88m final close for its Ascent Myanmar Growth Fund. The vehicle will make 10-15 investments in SMEs active in the consumer, education, financial services, health care, technology, media, and telecommunications sectors in Myanmar. Read more… Read More
Yingke Private Equity has reached a USD1.5b final close for the Yingke China Core Asset Strategic Allocation Fund, a vehicle focused on investments in core technology and biomedical science assets in China. Read more… Read More
GIC has agreed to acquire a 17.5% stake in AC Energy Philippines, a Philippines-based renewable energy platform, for USD412.5m. Read more… Read More
Ontario Teachers’ Pension Plan Board and Abu Dhabi Investment Authority have committed USD1.25b to Equis Development, a Singapore-based renewable energy and waste infrastructure developer and operator. Read more… Read More
Legend Capital and Lyfe Capital led a CNY1.5b (approximately USD226.6m) Series B for China-based biotech firm RecBio, with participation from Sequoia Capital and Temasek’s Vertex Ventures. Other investors include China’s HT Capital, Co-Stone Asset Management, Yuanbio Venture Capital, Qingsong Capital, and China Everbright Limited. Read more… Read More
(default archive template)